ClearPoint Neuro, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $37.0M | $31.4M | $24.0M | $20.6M | $16.3M | $12.8M | $11.2M | $7.4M |
| Cost of Revenue | $14.3M | $12.3M | $10.3M | $7.0M | $5.2M | $3.7M | $3.9M | $2.4M |
| Gross Profit | $22.7M | $19.1M | $13.6M | $13.5M | $11.1M | $9.1M | $7.3M | $4.9M |
| Gross Margin | 61.4% | 60.9% | 56.8% | 65.8% | 68.2% | 71.1% | 64.9% | 66.9% |
| Operating Expenses | ||||||||
| Research & Development | $13.9M | $12.4M | $11.7M | $10.9M | $9.3M | $4.7M | $2.8M | $2.3M |
| SG&A Expense | $16.5M | $12.0M | $11.8M | $9.6M | $8.0M | $5.3M | $4.3M | $4.3M |
| Operating Income | $-24.2M | $-19.7M | $-22.4M | $-16.3M | $-13.4M | $-6.2M | $-4.6M | $-5.2M |
| Operating Margin | -65.4% | -62.9% | -93.7% | -79.5% | -82.1% | -48.5% | -41.0% | -71.4% |
| Interest Expense | — | — | — | $81.0K | $973.0K | $1.4M | $955.0K | $980.4K |
| Pretax Income | $-25.5M | $-18.9M | — | — | — | — | — | — |
| Income Tax Expense | $55.0K | $12.0K | $8.0K | $0 | $0 | $0 | — | — |
| Net Income | $-25.5M | $-18.9M | $-22.1M | $-16.4M | $-14.4M | $-6.8M | $-5.5M | $-6.2M |
| Net Margin | -69.1% | -60.3% | -92.2% | -80.0% | -88.4% | -52.9% | -49.4% | -83.8% |
| EPS (Basic) | $-0.90 | $-0.70 | $-0.90 | $-0.68 | $-0.69 | $-0.43 | $-0.42 | $-0.56 |
| EPS (Diluted) | $-0.90 | $-0.70 | $-0.90 | $-0.68 | $-0.69 | $-0.43 | $-0.42 | $-0.56 |
| Shares Outstanding (Basic) | 28.3M | 27.0M | 24.6M | 24.2M | 20.7M | 17.0M | 15.2M | 11.0M |
| Shares Outstanding (Diluted) | 28.3M | 27.0M | 24.6M | 24.2M | 20.7M | 17.0M | 15.2M | 11.0M |
| Dividends Per Share | — | — | — | — | — | — | — | — |